Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F13%3A43907479" target="_blank" >RIV/00216208:11120/13:43907479 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11150/13:10138950 RIV/00216208:11140/13:10138950 RIV/00179906:_____/13:10138950 RIV/00064173:_____/13:#0000356 RIV/00669806:_____/13:10138950

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study

Original language description

To analyze the impact of abciximab pretreatment in this high-risk population of MI patients. The present study was a retrospective subanalysis of the multicentre randomized Routine Upfront Abciximab Versus Standard Peri-Procedural Therapy in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock (PRAGUE-7) study, which included 80 MI patients in CS undergoing primary percutaneous coronary intervention (PCI). Patients were randomly assigned into group A (routine pretreatment with anabciximab bolus followed by a 1 h abciximab infusion) and group B (standard therapy). The subanalysis included 37 patients requiring MV. Seventeen patients were in group A and 20 were in group B. The primary end point (death/stroke/reinfarction/new severe renal failure) at 30 days, procedural success (thrombosis in myocardial infarction [TIMI] flow) and frequency of bleeding were assessed. The ?(2) and Student's t tests were used for statistical analysis; P<0.05 was considered to be sta

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Experimental and Clinical Cardiology

ISSN

1205-6626

e-ISSN

—

Volume of the periodical

18

Issue of the periodical within the volume

2

Country of publishing house

CA - CANADA

Number of pages

4

Pages from-to

81-84

UT code for WoS article

000322439400015

EID of the result in the Scopus database

—